Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia
Clinical trial NCT00776321 · COMPLETED
Trial details
- NCT number
- NCT00776321
- Sponsor
- Karo Bio AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2007-10-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.